{"schema_version":"secwatch.filing_event.v1","accession":"0000029644-24-000093","form_type":"8-K","ticker":"DCI","cik":"0000029644","company_name":"DONALDSON Co INC","filed_at":"2024-08-28T23:59:59+00:00","discovered_at":"2026-05-14T18:03:15.463433+00:00","generated_at":"2026-05-31T07:17:38.376707+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Donaldson posts record Q4 sales $935M (+6.4%), GAAP EPS $0.90 (+20%), adjusted $0.94","bullets":["Q4 revenue $935M (+6.4% YoY); GAAP EPS $0.90 (+20%); adjusted EPS $0.94 vs $0.78.","Full-year FY2024 sales $3.6B (+4.5%), GAAP EPS $3.38 (+16.6%), adjusted EPS $3.42.","FY2025 guidance: sales growth 2-6%, adjusted EPS $3.56-$3.72; operating margin 15.3-15.9%.","Updated FY2026 targets: total sales CAGR 3-7% (down from 4-8%); Life Sciences CAGR cut to 5-11%.","Q4 footprint optimization restructuring charges $6.4M (severance); returned $286M to shareholders in FY2024."],"urls":{"canonical":"https://secwatch.observer/filing/0000029644-24-000093","json":"https://secwatch.observer/filing/0000029644-24-000093.json","markdown":"https://secwatch.observer/filing/0000029644-24-000093.md","text":"https://secwatch.observer/filing/0000029644-24-000093.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/29644/000002964424000093/0000029644-24-000093-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/29644/000002964424000093/dci-20240828.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T07:17:38.376707+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}